Reading Time: 8 minutes (Update 16Sept09) Brean Murry is out with a selling rating with Emdeon (source: StreetInsider). Quote: While investors may be focusing on the potential benefit from healthcare reform, we view the benefit as a potential one-time boost to the growth rate in claims that will revert back to the low-single digits after the anniversary of enrollment…We
Reading Time: 3 minutes (Update 2, May 20) Bought it back, looks like it has more room to run 
(Update May 19) Sold out my WX positions. I had a second thought on the stock. (Original) Formerly Wuxi Pharma Tech, the name change was to reflect the US based Apptec acquisition a year ago. I have bought and
Reading Time: 2 minutes First saw Rosetta Stone at the mall couple years ago (the kiosk). More recently saw its Ads on the TV. Today comes a monumental day for the company (bloomberg news, IPOHome, Yahoo Finance), the IPO (as old Warren says IPO stands for its probably overpriced). Fun and emotion aside, I think this language thing may
Reading Time: < 1 minute I remember reading this last year, this morning I read it from Yahoo Finance. Here is the prospectus at SEC, and here is a glimpse at IPOHome. It looks like they are going to IPO on Feb 10 (from the roadshow, again from IPOHome). I think most people heard about their product enfamil (Amazon, Wiki),
Reading Time: < 1 minute (Update Sept 5) It seems there are anti-trust concern about this acquisition. Some source says if this merge approved, Coca Cola will have 40% of juice market share in China. Another concern is, like many Chinese companies (Sohu, Netease), Huiyuan is actually registered in Cayman Island, theoritically it is M&A between two foreign companies. It
Reading Time: < 1 minute (Spreadtrum A/R and inventory from 4Q 06 to 2Q 08, click to enlarge) As shown in the picture above, their A/R (account receivable) jumped from $1.4 m on Mar 31 to 17.4 m June 30; inventory did not reduced much. This is also evident from its reduced cash postion. Read more details from its earning
Reading Time: 2 minutes I felt lucky I did sell some Spreadtrum (Nasdaq:SPRD) shares a short while ago when it exceeded $6 (a quick pop). But I don’t know why I bought some back couple days ago at $4.48. I did not bet on earning these days, but this one had dropped quite a bit from the pop, and
Reading Time: 2 minutes By now it’s no secret that CROX stock failed. After it issued horrendous 2Q 08 preliminary results and full year guidance yesterday afternoon (refer to MarketWatch for more details). I don’t want to dive into the numbers and add salt to injury. I traded the stock last year until this Feb. when I realized it
Reading Time: 3 minutes (Update July 8) More about the value of SPRD. Last month Datang sold its 32.1% stake in TD chip maker T3G, for 122 m CNY. This values T3G at (122m) / 32.1% = 380 m CNY. That’s $54.3 m (assume $1 = 7 CNY), and I will use that number for the TD business of
Reading Time: < 1 minute Obviously I pulled trigger too earlier on this one, SpreadTrum Communications (Nasdaq: SPRD). Here is a Speadsheet which has the revenue numbers for recent quarters. I think one reason for the continued pressure is the slow cell phone market, as indicated by the shipments slowdown of MediaTek, a bigger rival of Spread. My current plan:
Recent Comments